Table 2.
Correlations between monocyte subpopulation and carotid plaque standardized uptake value (SUV) and target-to-background ratio (TBR). * indicates significant result. WBC indicates whole blood count.
| Cellular populations | Plaque SUV |
Plaque TBR |
||
|---|---|---|---|---|
| r Spearman | p | r Spearman | p | |
| Total monocytes (count) | −0.58 | 0.05 | −0.58 | 0.05 |
| Monocytes/WBC (%) | 0.08 | 0.42 | −0.33 | 0.19 |
| CD14++CD16− classical (% of monocytes) | 0.57 | 0.06 | −0.10 | 0.40 |
| CD14++CD16− classical (count) | −0.25 | 0.26 | −0.47 | 0.11 |
| CD14++CD16+ intermediate (% of monocytes) | −0.05 | 0.46 | −0.20 | 0.30 |
| CD14++CD16+ intermediate (count) | −0.36 | 0.16 | −0.40 | 0.13 |
| CD14+CD16+ nonclassical (% of monocytes) | −0.48 | 0.10 | 0.12 | 0.39 |
| CD14+CD16+ nonclassical (count) | −0.73 | 0.01* | 0.01 | 0.50 |
| HLADR+CD14++CD16− classical (% of monocytes) | −0.50 | 0.09 | 0.18 | 0.32 |
| HLADR+CD14++CD16− classical (count) | −0.82 | 0.005* | −0.58 | 0.05 |
| HLA-DR+CD14++CD16+ intermediate (% of monocytes) | −0.53 | 0.07 | −0.27 | 0.23 |
| HLA-DR+CD14++CD16+ intermediate (count) | −0.66 | 0.03* | −0.38 | 0.15 |
| HLA-DR+CD14+CD16+ nonclassical (% of monocytes) | −0.17 | 0.34 | 0.28 | 0.23 |
| HLA-DR+CD14+CD16+ nonclassical (count) | −0.65 | 0.03* | 0.05 | 0.46 |
| Total lymphocytes (count) | −0.07 | 0.44 | 0.07 | 0.44 |
| Lymphocytes/WBC (%) | 0.22 | 0.29 | 0.30 | 0.22 |
| CD3+CD4+ T cells (% of lymphocytes) | 0.27 | 0.25 | 0.20 | 0.31 |
| CD3+CD4+ T cells (count) | 0.25 | 0.26 | 0.13 | 0.37 |
| HLA-DR+CD3+CD4+ T cells (% of lymphocytes) | 0.12 | 0.39 | 0.42 | 0.13 |
| HLA-DR+ CD3+CD4+ T cells (count) | 0.22 | 0.29 | 0.47 | 0.10 |
In bold are underlined correlations with a p-value of 0.05 or inferior.